Northern Trust Portfolio holdings
AUM
$727B
1-Year Return
23.08%
Northern Trust Corporation, founded in 1889 and headquartered in Chicago, Illinois, is a prominent financial services firm specializing in wealth management, asset management, and asset servicing for high-net-worth individuals, families, and institutions. Known for its conservative and client-focused approach, it manages hundreds of billions in assets, offering trust and custody services, investment solutions, and banking products tailored to affluent clients and organizations like foundations and endowments. The company has built a reputation for reliability and discretion, serving as a custodian for a significant portion of global institutional assets while maintaining a strong presence in private banking.
This Quarter Return
-14.52%
1 Year Return
+23.08%
3 Year Return
+97.56%
5 Year Return
+177.34%
10 Year Return
+414.74%
AUM
$467B
AUM Growth
-$102B
(-18%)
Cap. Flow
-$8.21B
Cap. Flow
% of AUM
-1.76%
Top 10 Holdings %
Top 10 Hldgs %
20.97%
Holding
4,884
New
138
Increased
1,684
Reduced
2,553
Closed
130
Top Buys
| 1 |
Warner Bros
WBD
|
+$303M |
| 2 |
Linde
LIN
|
+$202M |
| 3 |
Dimensional US Marketwide Value ETF
DFUV
|
+$187M |
| 4 |
FlexShares STOXX Global Broad Infrastructure Index Fund
NFRA
|
+$180M |
| 5 |
VICI Properties
VICI
|
+$171M |
Top Sells
| 1 |
Apple
AAPL
|
+$848M |
| 2 |
Microsoft
MSFT
|
+$690M |
| 3 |
AT&T
T
|
+$491M |
| 4 |
CERN
Cerner Corp
CERN
|
+$368M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$238M |
Sector Composition
| 1 | Technology | 22.08% |
| 2 | Healthcare | 14.01% |
| 3 | Financials | 11.92% |
| 4 | Consumer Discretionary | 9.56% |
| 5 | Industrials | 7.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2976
Lifecore Biomedical
LFCR
$281M
| $2.31M | ﹤0.01% |
231,786
-2,256
| -1% | -$22.5K |
|
2977
Akero Therapeutics
AKRO
$3.48B
| $2.31M | ﹤0.01% |
244,278
+8,353
| +4% | +$79K |
|
2978
Tenaris
TS
$18.7B
| $2.31M | ﹤0.01% |
89,892
-6,579
| -7% | -$169K |
|
2979
Kodiak Sciences
KOD
$489M
| $2.3M | ﹤0.01% |
301,239
-15,015
| -5% | -$115K |
|
2980
iShares US Real Estate ETF
IYR
$3.65B
| $2.3M | ﹤0.01% |
24,986
+1,890
| +8% | +$174K |
|
2981
Prospect Capital
PSEC
$1.29B
| $2.29M | ﹤0.01% |
327,752
+27,112
| +9% | +$190K |
|
2982
Entravision Communication
EVC
$226M
| $2.29M | ﹤0.01% |
501,833
-5,456
| -1% | -$24.9K |
|
2983
United States Lime & Minerals
USLM
$3.63B
| $2.29M | ﹤0.01% |
108,225
-640
| -0.6% | -$13.5K |
|
2984
Lindblad Expeditions
LIND
$735M
| $2.28M | ﹤0.01% |
281,168
-8,178
| -3% | -$66.2K |
|
2985
The Joint Corp
JYNT
$154M
| $2.27M | ﹤0.01% |
148,567
-2,570
| -2% | -$39.3K |
|
|
HLTH
2986
DELISTED
Cue Health Inc. Common Stock
HLTH
| $2.27M | ﹤0.01% |
709,082
+611,932
| +630% | +$1.96M |
|
2987
Ooma
OOMA
$345M
| $2.27M | ﹤0.01% |
191,462
+424
| +0.2% | +$5.02K |
|
2988
iShares MSCI EAFE Min Vol Factor ETF
EFAV
$5.46B
| $2.27M | ﹤0.01% |
35,773
+4,317
| +14% | +$273K |
|
|
HYZN
2989
DELISTED
Hyzon Motors Inc. Class A Common Stock
HYZN
| $2.26M | ﹤0.01% |
15,402
+11,886
| +338% | +$1.75M |
|
2990
Astronics
ATRO
$1.41B
| $2.26M | ﹤0.01% |
222,504
-8,910
| -4% | -$90.6K |
|
2991
Instil Bio
TIL
$163M
| $2.26M | ﹤0.01% |
24,403
+4,486
| +23% | +$415K |
|
2992
Powell Industries
POWL
$3.47B
| $2.24M | ﹤0.01% |
95,845
-15,707
| -14% | -$367K |
|
2993
DHI Group
DHX
$141M
| $2.24M | ﹤0.01% |
450,218
+284,009
| +171% | +$1.41M |
|
|
STR
2994
DELISTED
Sitio Royalties
STR
| $2.23M | ﹤0.01% |
96,255
+11,156
| +13% | +$259K |
|
|
CELL
2995
DELISTED
PhenomeX Inc. Common Stock
CELL
| $2.23M | ﹤0.01% |
447,956
+31,682
| +8% | +$157K |
|
|
RIDE
2996
DELISTED
Lordstown Motors Corp. Class A Common Stock
RIDE
| $2.22M | ﹤0.01% |
93,858
+5,617
| +6% | +$133K |
|
2997
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$30.8B
| $2.22M | ﹤0.01% |
2,014,781
+685,130
| +52% | +$754K |
|
2998
Big 5 Sporting Goods
BGFV
$32.8M
| $2.21M | ﹤0.01% |
197,540
-1,589
| -0.8% | -$17.8K |
|
2999
Vital Farms
VITL
$2.17B
| $2.21M | ﹤0.01% |
252,846
+26,369
| +12% | +$231K |
|
3000
Harvard Bioscience
HBIO
$19.7M
| $2.21M | ﹤0.01% |
614,115
+157,631
| +35% | +$568K |
|